Browsing by Subject "ICI118,551"
Now showing items 1-1 of 1
-
beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration
(2014)Context: Propranolol, atenolol, and ICI118,551 are non-selective beta-adrenergic receptor (AR), beta(1)-AR, and beta(2)-AR antagonists, respectively. Objective: We investigated the efficacy of propranolol, atenolol, and ...